CASE REPORTS
JOURNAL ARTICLE
Add like
Add dislike
Add to saved papers

Severe anemia of rapid onset in an inmunocompromised host.

We describe a case of pure red cell aplasia developing within two months after kidney transplant in a patient who was actively receiving immunosuppression. His hemoglobin was 9.5 g/dL and his reticulocyte count was 0%. WBC and platelet counts were normal and a bone marrow showed hypercellularity with normal myelocytic and megakaryocytic elements. The erythrocytic series was completely absent except for an increased number of giant proerythronormoblasts with cytoplasmic vacuolization. The titers for IgG and IgM for Parvovirus were negative. However, DNA PCR for Parvovirus B19 was positive. After receiving IV human immunoglobulin, the patient's hemoglobin increased in 4-6 weeks to 13.1 g/dL and his reticulocyte count became normal. The cause of his anemia was attributed to Parvovirus B19. Parvovirus B19 should be considered as a cause of unexplained progressive anemia in this setting and in any immunosuppressed patient. The reticulocyte count, bone marrow picture and PCR for DNA for Parvovirus B19 are essential for diagnosis.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app